BiotechTube
Home/Pipeline/Cell‑based LAIV platform

Cell‑based LAIV platform

Seasonal & Pandemic Influenza

Pre‑clinical/Phase 1Active

Key Facts

Indication
Seasonal & Pandemic Influenza
Phase
Pre‑clinical/Phase 1
Status
Active
Company
BioDiem

About BioDiem

Australian biotech licensing LAIV influenza vaccine technology for global partners.

View full company profile

Therapeutic Areas

Infectious Diseases